11 results
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
31 Jan 22
Gamida Cell Announces Appointment of Anat Cohen-Dayag and Naama Halevi-Davidov to its Board of Directors
4:31pm
is crucial to our mission to create cures for people living with serious diseases.”
Dr. Anat Cohen-Dayag has over 25 years of experience in the biotech
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
2 Jun 22
Gamida Cell Completes
7:31am
of this BLA submission is a key inflection point in our mission to deliver a new treatment option for patients with blood cancers. We look forward
6-K
EX-99.1
GMDAQ
Gamida Cell Ltd
13 Oct 20
Gamida Cell and Be The Match BioTherapies® Expand Strategic Collaboration
8:21am
supply chain.
“Gamida Cell’s work to bring a new stem cell graft source to patients aligns with our core mission to help organizations deliver
8-K
EX-99.1
GMDAQ
Gamida Cell Ltd
19 Sep 22
Departure of Directors or Certain Officers
7:06am
Gamida Cell as we work to fulfill our mission of creating cures for blood cancers and serious hematologic diseases. Under Julian’s leadership, the team
6-K
EX-99.1
GMDAQ
Gamida Cell Ltd
26 Oct 21
Gamida Cell to Present NAM-Enabled, Genetically Modified NK Cell Therapy Pipeline and Update on GDA-201 at Today’s Virtual R&D Day
7:30am
will help to further our mission to bring cancer patients potentially curative cell therapies.”
Update Regarding NK Cell Therapy Programs:
During today’s
8-K
EX-99.1
fc8t3 bp6a
1 Aug 22
Gamida Cell Announces FDA Acceptance of
7:30am
DEFA14A
a1ncz8 3mn1uzsy
29 Sep 23
Additional proxy soliciting materials
8:41am
8-K
EX-99.1
xdlk9fvi6wutec4e njw
27 Sep 23
Regulation FD Disclosure
4:43pm
8-K
EX-99.1
frdwub8jigd2ucc4 5z4
15 Aug 22
Gamida Cell Reports Second Quarter 2022 Financial Results
7:15am
6-K
EX-99.1
bjh 5tkgqpdczmsszp90
13 Aug 21
Report of Foreign Private Issuer
4:04pm
8-K
EX-99.1
3l1c1sz6lvpd0dk6ne
14 Nov 22
Gamida Cell Reports Third Quarter 2022 Financial Results
7:15am
- Prev
- 1
- Next